CHARACTERIZATION OF CAT DANDER-SPECIFIC T-LYMPHOCYTES FROM ATOPIC PATIENTS

Citation
Rjj. Vanneerven et al., CHARACTERIZATION OF CAT DANDER-SPECIFIC T-LYMPHOCYTES FROM ATOPIC PATIENTS, The Journal of immunology, 152(8), 1994, pp. 4203-4210
Citations number
60
Categorie Soggetti
Immunology
Journal title
The Journal of immunology
ISSN journal
00221767 → ACNP
Volume
152
Issue
8
Year of publication
1994
Pages
4203 - 4210
Database
ISI
SICI code
0022-1767(1994)152:8<4203:COCDTF>2.0.ZU;2-1
Abstract
Fel d I, the major cat dander allergen, is recognized by serum IgE of more than 80% of all cat-allergic patients. Because IgE synthesis by B lymphocytes is under the control of T lymphocytes, we studied the spe cificity and lymphokine production profiles of cat dander-specific T l ymphocytes. Polyclonal cat dander-specific T cell lines were found to react with purified Fel d I, but not with cat albumin, the only other characterized cat allergen. Similarly, within a panel of CD4(+) T lymp hocyte clones (TLC) that was generated from these cat dander-specific T cell lines, 5 of 16 TLC were found to react with Fel d I, and 0 of 1 6 with cat albumin. The remaining 11 TLC were shown to recognize at le ast two different proteins. In general, the TLC had a high IL-4/IFN-ga mma production ratio, and could recognize the cat dander extract in an HLA-DR, HLA-DQ, or HLA-DP restricted manner. In addition, five distin ct T cell epitopes of Fel d I were identified by using a panel of over lapping synthetic peptides of both chains of Fel d I. The data present ed here indicate that, even though multiple proteins in cat dander ext ract are recognized by T lymphocytes of allergic patients, Fel d I, th e major IgE binding allergen, is also important in T cell activation. The fact that the cat-specific TLC are Th2-like indicates that these c ells may play an important role in the pathophysiology of allergic res ponses to cat allergens. However, the diversity of HLA-class II restri ction of cat dander- and Fel d I-specific TLC and the presence of mult iple T cell epitopes in the allergen may complicate future immunothera pies.